Alkermes plc. Intangible Assets, Net (Including Goodwill)
Alkermes plc. (ALKS) had Intangible Assets, Net (Including Goodwill) of $83.84 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Goodwill and Other
us-gaap:IntangibleAssetsNetIncludingGoodwill · last filed 2026-02-25
- 2025-12-31: Intangible Assets, Net (Including Goodwill) $83.84M.
- 2025-09-30: Intangible Assets, Net (Including Goodwill) $83.86M.
- 2025-06-30: Intangible Assets, Net (Including Goodwill) $83.88M.
- 2025-03-31: Intangible Assets, Net (Including Goodwill) $83.90M.
| Period end | Intangible Assets, Net (Including Goodwill) |
|---|---|
| 2025-12-31 | $83.84M 10-K · filed 2026-02-25 |
| 2025-09-30 | $83.86M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $83.88M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $83.90M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $83.92M 10-K · filed 2026-02-25 |
| 2024-09-30 | $83.93M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $83.94M 10-Q · filed 2024-07-24 |
| 2023-12-31 | $85.02M 10-K · filed 2025-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |